journal article·2020-01Open access

Chiral Supraparticles for Controllable Nanomedicine

Jihyeon Yeom, Pedro P. G. Guimaraes, Hyo Min Ahn, Bo‐Kyeong Jung, Quanyin Hu, Kevin McHugh, Michael J. Mitchell, Chae‐Ok Yun, Robert Langer, Ana Jaklenec

Advanced Materials· Volume 32· Issue 1

Abstract

Abstract Chirality is ubiquitous in nature and hard‐wired into every biological system. Despite the prevalence of chirality in biological systems, controlling biomaterial chirality to influence interactions with cells has only recently been explored. Chiral‐engineered supraparticles (SPs) that interact differentially with cells and proteins depending on their handedness are presented. SPs coordinated with d‐chirality demonstrate greater than threefold enhanced cell membrane penetration in breast, cervical, and multiple myeloma cancer cells. Quartz crystal microbalance with dissipation and isothermal titration calorimetry measurements reveal the mechanism of these chiral‐specific interactions. Thermodynamically, d‐SPs show more stable adhesion to lipid layers composed of phospholipids and cholesterol compared to l‐SPs. In vivo, d‐SPs exhibit superior stability and longer biological half‐lives likely due to opposite chirality and thus protection from endogenous proteins including proteases. This work shows that incorporating d‐chirality into nanosystems enhances uptake by cancer cells and prolonged in vivo stability in circulation, providing support for the importance of chirality in biomaterials. Thus, chiral nanosystems may have the potential to provide a new level of control for drug delivery systems, tumor detection markers, biosensors, and other biomaterial‐based devices.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Lipid Membrane Structure and Behavior · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge MA 02139 USA

Department of Physiology and Biophysics Institute of Biological Sciences Universidade Federal de Minas Gerais Belo Horizonte MG 31270‐901 Brazil

Department of Bioengineering College of Engineering Hanyang University Seoul 04763 Republic of Korea

Department of Bioengineering University of Pennsylvania Philadelphia PA 19104‐6321 USA

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico · National Institutes of Health · American Cancer Society · National Research Foundation of Korea

References (50)

Show source-provided references
1. 10.1038/s41586-018-0034-110.1038/s41586-018-0034-1 ↗
2. 10.1126/science.aao717210.1126/science.aao7172 ↗
3. 10.1038/s41570-017-004510.1038/s41570-017-0045 ↗
4. 10.1073/pnas.161146711410.1073/pnas.1611467114 ↗
5. 10.1038/s41467-018-06400-010.1038/s41467-018-06400-0 ↗
6. 10.2165/00003495-199600525-0000310.2165/00003495-199600525-00003 ↗
7. 10.1038/nrd91510.1038/nrd915 ↗
8. 10.1039/C7CS00253J10.1039/C7CS00253J ↗
9. 10.1021/acs.nanolett.8b0243310.1021/acs.nanolett.8b02433 ↗
10. 10.3109/03602532.2014.88709410.3109/03602532.2014.887094 ↗
11. 10.59566/IJBS.2006.208510.59566/IJBS.2006.2085 ↗
12. 10.1038/s41467-016-0009-610.1038/s41467-016-0009-6 ↗
13. 10.1038/natrevmats.2017.3910.1038/natrevmats.2017.39 ↗
14. 10.1021/acsnano.7b0669110.1021/acsnano.7b06691 ↗
15. 10.1002/adma.20180179010.1002/adma.201801790 ↗
16. 10.1002/admi.20150041110.1002/admi.201500411 ↗
17. 10.1038/nrd175110.1038/nrd1751 ↗
18. 10.1038/nrc164910.1038/nrc1649 ↗
19. 10.1038/nature1076910.1038/nature10769 ↗
20. 10.1016/j.tibs.2009.02.00510.1016/j.tibs.2009.02.005 ↗
21. 10.1186/2044-7248-4-110.1186/2044-7248-4-1 ↗
22. 10.1038/486S7a10.1038/486S7a ↗
23. 10.1038/oncsis.2015.4910.1038/oncsis.2015.49 ↗
24. 10.1158/0008-5472.CAN-10-389410.1158/0008-5472.CAN-10-3894 ↗
25. 10.1021/cr400228710.1021/cr4002287 ↗
26. 10.1038/s41557-018-0083-y10.1038/s41557-018-0083-y ↗
27. 10.1002/adma.20180207510.1002/adma.201802075 ↗
28. 10.1126/sciadv.160115910.1126/sciadv.1601159 ↗
29. 10.1073/pnas.87.12.476110.1073/pnas.87.12.4761 ↗
30. 10.1186/s12951-018-0383-910.1186/s12951-018-0383-9 ↗
31. 10.1038/nmat412510.1038/nmat4125 ↗
32. 10.1038/ncomms459310.1038/ncomms4593 ↗
33. 10.1038/nnano.2011.12110.1038/nnano.2011.121 ↗
34. 10.1039/C6ME00016A10.1039/C6ME00016A ↗
35. 10.1002/adom.20170018210.1002/adom.201700182 ↗
36. Pigliacelli C. · ACS Nano · 2019 · 13 · 2158
37. 10.1021/ja305386510.1021/ja3053865 ↗
38. 10.1021/ja800256r10.1021/ja800256r ↗
39. 10.1021/jp108347b10.1021/jp108347b ↗
40. 10.1021/ja909599k10.1021/ja909599k ↗
41. 10.1021/la203138k10.1021/la203138k ↗
42. 10.1002/jat.295710.1002/jat.2957 ↗
43. 10.1016/j.nano.2015.03.00410.1016/j.nano.2015.03.004 ↗
44. 10.1038/nbt134010.1038/nbt1340 ↗
45. 10.1021/acsnano.5b0132010.1021/acsnano.5b01320 ↗
46. 10.1021/acsbiomaterials.8b0106210.1021/acsbiomaterials.8b01062 ↗
47. 10.1038/nprot.2010.6510.1038/nprot.2010.65 ↗
48. 10.1016/j.bpc.2015.05.00610.1016/j.bpc.2015.05.006 ↗
49. 10.1016/B978-0-444-42277-4.50008-910.1016/B978-0-444-42277-4.50008-9 ↗
50. 10.1007/978-3-642-39790-510.1007/978-3-642-39790-5 ↗